This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of other and unspecified genital organs
CD2_INSITU_GENITAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ organorum genitalium aliorum sive non specificatorum
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified genital organs
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified genital organs
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 603 | 603 | - |
| Unadjusted period prevalence (%) | 0.21 | 0.21 | - |
| Median age at first event (years) | 59.66 | 59.66 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 548
- Matched controls
- 5480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ULA02
NOMESCO Finland
Kolposcopy
28.4
234.6
363
353
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
63.8
203.3
234
63
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
1053.3
164.7
153
*
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
+∞
152.4
139
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
144.3
132
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
12.9
141.9
301
471
LEB00
NOMESCO Finland
Biopsy of vagina
48.8
134.5
163
47
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
128.3
118
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
114.7
106
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
70.0
98.8
112
20
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
110.9
93.6
100
11
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
92.3
86
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
+∞
90.1
84
*
LFC00
NOMESCO Finland
Partial excision of vulva
462.8
82.3
80
*
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
+∞
81.3
76
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
8.3
78.8
200
354
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
10.7
77.7
164
211
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
62.7
59
*
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
144.5
61.3
64
5
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
22.9
60.8
89
46
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
582.6
54.5
53
*
B01AB10
ATC
tinzaparin; parenteral
10.9
50.9
102
112
PJA12
NOMESCO Finland
Sentinel node biopsy
522.0
49.2
48
*
115
Kela drug reimbursment
Breast cancer
+∞
48.7
46
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
8.3
46.4
110
161
D06BB10
ATC
imiquimod; topical
10.7
46.0
93
103
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
9.7
45.4
97
119
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
49.7
45.0
54
12
H02AB02
ATC
dexamethasone; systemic
28.0
42.5
58
23
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.2
40.7
96
138
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
40.1
38
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
404.1
38.5
38
*
N89.0
ICD-10 Finland
Mild vaginal dysplasia
88.5
37.3
41
5
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.2
35.8
284
1378
128
Kela drug reimbursment
Cancers of female genital organs
369.6
35.4
35
*
N90.0
ICD-10 Finland
Mild vulvar dysplasia
52.3
33.0
39
8
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
32.6
31
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
31.6
30
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
31.0
73
103
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.2
30.3
52
40
N87.0
ICD-10 Finland
Mild cervical dysplasia
9.0
27.7
60
74
JN4BD
NOMESCO Finland
Extensive body CT
7.2
26.7
67
104
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
26.3
25
*
ZXC96
NOMESCO Finland
Robot assisted procedure
28.6
26.1
35
13
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
19.9
26.0
39
21
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.7
25.9
57
72
HAC20
NOMESCO Finland
Total mastectomy
+∞
25.2
24
*
JN4AD
NOMESCO Finland
Body CT examination
10.1
24.8
50
54
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.9
24.8
58
81
HA1AA
NOMESCO Finland
X-ray mammography
6.7
24.7
65
108
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.8
24.6
116
361
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
10.6
24.0
47
48
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
6.9
24.0
62
100
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
130.7
23.8
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
22.9
205
995
WF002
NOMESCO Finland
Radical radiotherapy
125.2
22.8
24
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
13.4
22.5
39
31
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
22.0
21
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
21.0
20
*
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
21.0
20
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
20.7
91
264
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
217.9
20.7
21
*
A04AA02
ATC
granisetron; systemic, transdermal
217.9
20.7
21
*
L02BA01
ATC
tamoxifen; oral
114.4
20.7
22
*
L02BG04
ATC
letrozole; oral
13.3
19.6
34
27
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
18.9
18
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
18.9
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
21.8
18.8
27
13
B01AB05
ATC
enoxaparin; parenteral
2.4
18.3
198
1036
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.0
18.2
29
19
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.8
17
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
17.8
17
*
D07AD01
ATC
clobetasol; topical
2.7
17.6
135
583
N95.0
ICD-10 Finland
Postmenopausal bleeding
3.1
17.3
104
381
D07.2
ICD-10 Finland
Carcinoma in situ: Vagina
+∞
16.7
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
130
Kela drug reimbursment
Malignant tumour
+∞
16.7
16
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
+∞
16.7
16
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
16.7
16
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
16.7
16
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
17.0
16.7
26
16
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
175.0
16.6
17
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
175.0
16.6
17
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.7
16.0
123
526
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
61.9
15.8
18
*
D07.3
ICD-10 Finland
Carcinoma in situ: Other and unspecified female genital organs
+∞
15.7
15
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
15.7
15
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
19.9
15.7
23
12
N76.6
ICD-10 Finland
Ulceration of vulva
22.8
15.6
22
10
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
6.7
15.6
40
64
ZZR00
NOMESCO Finland
Flap of skin
39.3
15.5
19
5
N90.4
ICD-10 Finland
Leukoplakia of vulva
24.2
15.2
21
9
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
14.6
14
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.6
14
*
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
+∞
14.6
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
14.6
14
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.3
14.3
77
261
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
14.2
111
478
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
13.6
13
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
26.5
13.4
18
7
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
15.5
13.2
21
14
N87.1
ICD-10 Finland
Moderate cervical dysplasia
5.8
13.1
37
68
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
13.1
227
1419
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.1
12.8
28
36
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
12.5
12
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.5
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.5
12
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
13.6
12.5
21
16
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
11.5
11
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
A04AA01
ATC
ondansetron; systemic, rectal
5.3
11.4
34
67
ZXC10
NOMESCO Finland
Use of laser
6.6
11.2
28
44
L03AA02
ATC
filgrastim; parenteral
44.2
11.0
13
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.7
10.7
79
326
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.2
10.7
18
14
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
8.8
10.6
22
26
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
10.4
10
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
10.4
10
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
56.0
9.7
11
*
WZC30
NOMESCO Finland
Teaching
2.7
9.6
66
261
SPAT1153
SPAT
Removal of sutures
1.9
9.5
182
1150
D06BB04
ATC
podophyllotoxin; topical
3.9
9.4
38
103
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
9.4
9
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.4
116
617
N02BE01
ATC
paracetamol; systemic, rectal
2.2
9.3
484
4246
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
5.1
9.2
28
57
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
9.3
9.1
18
20
ZX120
NOMESCO Finland
Intravenous
3.2
9.1
47
156
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
12.8
8.9
15
12
UJF32
NOMESCO Finland
Coloscopy
1.9
8.8
152
921
J01DB01
ATC
cefalexin; oral
1.9
8.8
449
3843
J02AC01
ATC
fluconazole; systemic
1.7
8.7
289
2158
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
8.6
166
1047
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
91.4
8.4
9
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.9
8.4
52
193
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
8.4
8
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
8.4
8
*
E0000UV
ATC
NA
1.7
8.3
230
1618
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
14.7
8.2
13
9
N02AA05
ATC
oxycodone; systemic
2.5
8.2
64
273
P01AB01
ATC
metronidazole; oral, rectal
1.7
8.2
257
1874
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
8.0
24
49
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
7.9
47
172
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.1
7.7
20
34
E000001
ATC
NA
1.9
7.7
128
759
ZZF00
NOMESCO Finland
Graft of adipose tissue
25.4
7.6
10
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.9
7.6
20
35
G01AA10
ATC
clindamycin; vaginal
1.9
7.5
128
767
SPAT1312
SPAT
General health counselling
1.7
7.5
196
1346
X76
ICPC
Malignant neoplasm breast female
81.1
7.4
8
*
J01EA01
ATC
trimethoprim; systemic
1.7
7.3
179
1204
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
LFD00
NOMESCO Finland
Vulvectomy
+∞
7.3
7
*
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
7.3
7
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
2.5
7.3
59
257
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
7.5
7.2
16
22
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
30.4
7.2
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.1
68
323
L57.0
ICD-10 Finland
Actinic keratosis
2.7
7.0
48
190
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.9
200
1407
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
14.0
6.9
11
8
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
6.9
89
480
Z3231
NOMESCO Finland
Registered nurse
1.8
6.9
140
890
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
11.1
6.8
12
11
ULC02
NOMESCO Finland
Hysteroscopy
2.5
6.7
51
217
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
6.6
67
325
C03CA01
ATC
furosemide; systemic
1.8
6.5
137
875
LFW96
NOMESCO Finland
Other operation on vulva or perineum
70.6
6.4
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
70.6
6.4
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
70.6
6.4
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.6
6.4
7
*
TQW20
NOMESCO Finland
Tatoe
70.6
6.4
7
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.2
6.4
31
100
A02BC02
ATC
pantoprazole; systemic
1.6
6.3
351
2892
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
18.3
6.3
9
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
6.3
25
69
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.3
6
*
H02AB06
ATC
prednisolone; systemic
1.6
6.2
256
1958
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.4
6.2
15
24
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
6.2
363
3028
LFE10
NOMESCO Finland
Plastic repair of vulva
12.7
6.1
10
8
S18
ICPC
Laceration/cut
1.6
6.0
209
1529
Z51.5
ICD-10 Finland
Palliative care
6.1
6.0
15
25
L04AA06
ATC
mycophenolic acid; systemic
5.6
6.0
16
29
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
6.0
57
271
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
3.5
6.0
26
77
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
139
79
22.57
177.09
3.8
1.8
—
—
—
0
0
(4035726)
148
117
16.44
158.82
1.5
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
71
23
34.86
110.28
4.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
345
1235
5.19
89.48
3.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
427
1875
5.38
83.88
5.0
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
141
264
6.67
75.64
3.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
414
2146
3.96
55.92
4.6
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
139
396
4.26
44.39
1.4
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
176
666
3.32
36.20
9.0
5.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
264
1349
2.70
30.56
2.4
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
411
3.47
29.76
4.1
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
217
1039
2.70
28.17
2.2
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
329
1988
2.44
25.34
5.1
3.3
g/l
36.0
36.2
0.41
305
1835
(3029937) Albumin [Presence] in Urine by Test strip
250
1372
2.40
23.44
5.1
3.9
estimate
0.0
0.0
0.50
64
448
(3007853) Bacteria identified in Skin by Aerobe culture
123
484
2.94
22.69
2.0
1.7
—
—
—
0
0
(3020891) Body temperature
60
154
4.22
21.43
4.9
4.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
76
240
3.48
20.18
4.1
4.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
221
1229
2.26
19.30
5.0
3.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
381
2636
2.21
19.09
4.9
3.7
estimate
0.0
0.0
0.80
66
440
(3021601) Nitrite [Presence] in Urine by Test strip
376
2616
2.16
18.19
5.9
5.1
estimate
0.0
0.0
0.50
61
443
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
344
2342
2.09
17.26
6.8
3.2
umol/l
9.3
10.3
1.57
329
2182
(3013650) Neutrophils [#/volume] in Blood by Automated count
380
2705
2.09
16.65
10.6
6.5
e9/l
4.0
4.1
0.81
347
2331
(3003396) Base excess in Arterial blood by calculation
102
441
2.58
15.34
3.8
5.8
mmol/l
0.9
1.4
0.72
76
350
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
315
2152
1.97
14.81
5.1
4.4
mmol/l
1.2
1.2
4.26
275
1894
(3042936) Bacteria identified in Isolate by Culture
123
591
2.36
14.68
2.3
1.8
—
—
—
0
0
(3015736) pH of Urine
299
2023
1.95
14.30
4.8
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
360
2593
1.96
14.29
4.9
3.7
estimate
0.0
0.0
0.00
63
448
(3023368) Bacteria identified in Blood by Culture
173
965
2.11
14.28
5.1
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
199
1184
2.02
13.70
6.0
4.0
kg/l
1.0
1.0
1.02
19
177
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
394
2.54
13.58
2.0
2.0
ml/min/173m2
60.8
68.0
1.10
34
165
(40768793) Breast Pathology biopsy report
29
62
4.86
12.95
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
648
2.19
12.65
2.9
2.2
mmol/l
0.8
0.8
2.76
116
590
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
471
3808
2.08
12.46
9.2
5.1
u/l
78.9
75.2
1.19
450
3513
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
291
2019
1.85
12.27
5.2
3.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
190
1149
1.95
12.26
7.8
4.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
260
1762
1.84
11.66
3.5
3.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
330
2407
1.82
11.59
6.0
4.9
mmol/l
1.2
1.2
5.10
274
2040
(3013826) Glucose [Moles/volume] in Serum or Plasma
363
2763
1.79
10.68
4.7
3.8
mmol/l
6.6
6.6
0.30
345
2547
(3000850) Epithelial cells [#/volume] in Urine
160
960
1.91
10.32
3.0
2.3
e6/l
6.2
8.6
0.91
138
842
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
249
2.61
10.21
3.3
1.4
ug/l
3.2
2.6
0.69
51
185
(3003694) ABO and Rh group [Type] in Blood
191
1219
1.83
10.11
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
302
2.45
9.99
1.4
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
253
1767
1.74
9.78
12.6
7.9
inr
1.2
1.2
0.12
58
512
(3015377) Calcium [Moles/volume] in Serum or Plasma
243
1684
1.74
9.62
3.7
2.0
mmol/l
2.4
2.4
0.72
208
1419
(3044889) 12 lead EKG panel
438
3586
1.81
9.44
4.7
3.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
209
1400
1.75
9.25
3.1
2.8
ng/l
1097.5
989.0
0.16
182
1166
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
79
382
2.23
9.10
4.7
3.6
u/l
239.1
232.7
0.21
74
355
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
5
24.42
8.94
2.8
1.0
u/ml
48.6
14.8
—
12
5
(3018418) pH of Serum or Plasma
208
1413
1.72
8.64
4.2
2.8
ph
7.4
7.4
1.77
34
229
(40768443) Skin Pathology biopsy report
49
200
2.58
8.21
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
79
400
2.12
8.10
2.6
2.3
ug/l
2.7
6.3
4.01
73
351
(36304419) Bacteria [Presence] in Urine
184
1230
1.71
8.00
3.8
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
21
6.30
7.74
1.4
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
219
1552
1.65
7.55
3.6
2.1
u/l
53.0
56.7
1.10
206
1408
(4281824)
17
37
4.70
7.44
1.1
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
182
1234
1.68
7.42
4.0
2.8
e6/l
0.3
0.4
0.93
147
923
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
112
674
1.81
6.92
2.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
8
13.97
6.91
1.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
247
1837
1.58
6.82
4.1
3.4
ng/l
21.0
45.3
0.61
165
1172
(3037467) Urinalysis macro (dipstick) panel - Urine
426
3610
1.61
6.53
5.6
4.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
11
18
6.21
6.45
1.8
1.7
—
49.2
—
0
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
92
3.03
6.35
2.8
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
190
1354
1.59
6.17
4.0
2.9
e6/l
24.4
50.7
1.29
158
1021
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
73
3.24
6.07
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
52
251
2.17
6.02
1.4
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
557
5124
2.14
5.97
20.3
11.2
mg/l
23.2
19.4
1.69
463
3896
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
16
6.34
5.97
2.1
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
309
2467
1.52
5.93
7.4
5.3
e9/l
0.0
0.0
1.41
280
2120
(3019198) Lymphocytes [#/volume] in Blood
314
2517
1.52
5.90
7.3
5.4
e9/l
1.8
1.9
3.25
287
2208
(3001604) Monocytes [#/volume] in Blood
307
2450
1.52
5.89
7.4
5.3
e9/l
0.5
0.6
0.58
278
2110
(3013115) Eosinophils [#/volume] in Blood
317
2558
1.50
5.70
7.6
5.6
e9/l
0.2
0.2
0.01
290
2239
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
483
1.83
5.68
2.0
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
17
5.96
5.64
2.5
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
116
747
1.68
5.59
3.6
2.4
e6/l
2.5
1.4
0.51
83
398
(3018095) Leukocytes [#/volume] in Urine
223
1682
1.52
5.49
4.3
3.4
e6/l
47.0
93.8
1.82
173
1124
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
429
1.85
5.42
2.0
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
85
2.90
5.30
1.5
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
572
5353
2.33
5.26
20.7
12.7
mmol/l
139.5
139.8
1.54
565
5204
(3022217) INR in Platelet poor plasma by Coagulation assay
92
565
1.74
5.26
38.0
22.6
inr
1.3
1.3
0.03
11
83
(3003458) Phosphate [Moles/volume] in Serum or Plasma
88
536
1.75
5.17
7.4
3.5
mmol/l
1.1
1.0
0.45
82
474
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
153
2.37
5.13
1.6
2.0
g/l
1.8
1.5
0.60
27
136
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
212
1602
1.50
5.10
2.5
2.1
u/l
130.6
143.6
0.38
202
1506
(3023103) Potassium [Moles/volume] in Serum or Plasma
572
5367
2.28
4.98
20.8
12.8
mmol/l
4.0
3.9
0.54
564
5205
(40761511) CBC panel - Blood by Automated count
572
5370
2.27
4.92
17.8
10.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
220
2.08
4.69
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
86
2.74
4.63
1.7
2.8
u/ml
0.3
0.4
1.32
11
54
(3045424) Erythrocytes [Presence] in Urine
22
81
2.78
4.56
1.2
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
281
1.93
4.48
1.9
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
449
3990
1.49
4.35
5.5
4.3
mm/h
14.3
12.1
2.26
414
3702
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
139
2.30
4.32
2.4
2.1
u/l
2140.9
4526.0
0.54
13
61
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
9
8.99
4.29
1.6
1.2
ug/l
14.5
15.8
—
8
9
(3035880) pH of Pleural fluid
8
9
8.99
4.29
1.3
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
125
874
1.54
4.24
3.3
2.4
mosm/kgh2o
479.3
515.3
1.19
109
740
(3020564) Creatinine [Moles/volume] in Serum or Plasma
579
5501
2.32
4.17
21.5
12.6
umol/l
71.3
69.3
0.85
579
5501
(3012516) Albumin [Mass/volume] in Urine
197
1521
1.44
4.07
3.8
3.1
mg/l
353.6
278.7
0.09
126
850
(40760892) CBC W Ordered Manual Differential panel - Blood
152
1120
1.48
4.00
4.9
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
971
1.50
4.00
1.7
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
28
3.98
3.99
1.9
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
206
1613
1.42
3.91
4.2
3.0
mmol/l
6.4
6.5
0.17
168
1353
(3026493) Urate [Moles/volume] in Serum or Plasma
161
1205
1.46
3.90
2.7
2.1
umol/l
7386.3
5125.7
0.17
141
1025
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
75
473
1.67
3.89
2.1
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
56
327
1.79
3.82
2.1
2.7
e9/l
73.4
72.9
0.03
45
250
(3049717) Cytology report of Urine Cyto stain
25
110
2.33
3.66
1.7
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
554
1.60
3.66
3.0
2.3
%
22.2
23.1
0.23
71
465
(3000991) Gas panel - Venous blood
51
294
1.80
3.63
5.0
6.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1171
1.44
3.54
1.5
1.7
mg/l
0.8
0.9
0.80
118
886
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
6
10.08
3.50
1.8
1.0
%
0.5
0.7
—
6
6
(3022948) Iron [Moles/volume] in Serum or Plasma
99
686
1.53
3.48
2.8
2.2
umol/l
12.1
13.7
1.31
87
623
(3017181) Myelocytes/100 leukocytes in Blood
60
370
1.69
3.40
4.0
3.9
%
0.9
0.7
0.23
27
64
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
73
475
1.61
3.36
2.0
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
444
1.63
3.33
1.6
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
40
220
1.88
3.32
4.6
3.3
ph
7.4
7.4
—
7
32
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
214
1.88
3.26
4.6
3.2
mmol/l
2.3
2.0
0.18
32
162
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
483
4439
1.44
3.21
5.3
4.5
pmol/l
15.0
14.7
1.40
445
4077
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
622
1.53
3.20
2.8
2.2
g/l
2.3
2.4
2.11
80
574
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
577
5526
2.02
3.20
13.7
8.8
u/l
23.8
23.1
0.60
565
5303
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
11
6.42
3.19
3.1
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
79
2.45
3.16
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
200
1608
1.36
3.12
4.5
3.8
mg/mmol
11.9
6.0
0.71
117
904
(3023199) Leukocytes [#/volume] in Pleural fluid
9
20
4.55
3.12
1.9
1.1
e6/l
767.6
1600.2
—
9
15
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
39
3.12
3.10
1.1
1.2
u/l
58.6
58.5
—
7
26
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
39
3.12
3.10
1.1
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
69
453
1.59
3.07
2.9
2.2
%
2.0
1.8
0.72
60
396
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
12
5.89
3.03
1.6
1.0
u/l
463.3
307.5
—
7
12
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
57
2.67
2.98
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
527
4944
1.52
2.97
15.2
9.9
ml/min/173m2
79.8
80.3
0.20
457
3938
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
52
2.73
2.90
1.5
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
79
543
1.52
2.89
1.4
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
125
941
1.41
2.87
3.2
2.1
mmol/l
2.5
2.4
1.63
109
829
(44790047)
10
31
3.26
2.78
1.8
1.5
—
—
—
0
0
(44806118)
10
31
3.26
2.78
1.8
1.5
—
—
—
0
0
(44790049)
10
31
3.26
2.78
1.8
1.5
—
—
—
0
0
(44790048)
10
31
3.26
2.78
1.8
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
57
367
1.61
2.76
3.7
2.7
mmol/l
2.1
2.2
0.12
46
297
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
42
2.89
2.76
1.5
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
6
8.39
2.75
1.8
1.0
%
1.8
44.7
—
5
6
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
72
2.40
2.75
1.5
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
72
2.40
2.75
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
82
577
1.49
2.69
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
15
4.71
2.60
1.6
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
38
2.93
2.59
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
74
514
1.50
2.59
3.6
3.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
25
3.64
2.58
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
11
5.50
2.55
1.3
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
41
248
1.70
2.54
1.6
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
165
1.86
2.54
1.9
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
75
2.30
2.53
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
75
2.30
2.53
1.8
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
253
2158
1.30
2.51
11.8
7.8
e9/l
0.0
0.0
0.94
219
1758
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
26
3.50
2.49
1.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
86
621
1.45
2.48
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
159
1.87
2.48
5.0
3.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
16
4.41
2.48
1.4
2.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
473
1.49
2.37
1.9
1.5
%
1.4
1.3
0.15
59
422
(3052851) Hemolysis interference index of Serum or Plasma
26
140
1.90
2.35
3.3
3.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
28
3.25
2.31
2.7
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
157
1.82
2.25
1.8
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
107
2.00
2.23
1.3
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
68
480
1.47
2.22
4.2
1.8
umol/l
5.3
5.1
0.09
60
408
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
54
2.44
2.21
2.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
124
975
1.34
2.17
1.7
1.7
nmol/l
1336.1
1207.8
0.78
98
714
(4034850)
30
174
1.76
2.17
18.1
8.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1540
1.29
2.15
4.4
2.4
u/l
30.9
28.8
0.48
170
1477
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
68
2.24
2.12
1.6
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
37
2.73
2.11
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
10
5.03
2.07
2.8
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
178
1.72
2.02
3.7
2.8
mmol/l
24.3
24.6
0.19
24
160
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
126
1.86
2.01
1.3
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
261
2286
1.25
1.96
8.4
5.7
%
8.3
8.2
0.13
247
2115
(3021440) Promyelocytes/100 leukocytes in Blood
52
357
1.50
1.96
4.4
4.0
%
0.1
0.0
0.71
21
59
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
33
2.75
1.94
2.2
3.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
266
2340
1.24
1.91
8.2
5.6
%
27.3
29.2
1.96
252
2160
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
530
5061
1.39
1.90
4.4
4.0
mmol/l
1.3
1.3
1.61
482
4615
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
174
1.70
1.89
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
34
214
1.62
1.86
8.7
5.9
mmol/l
25.0
25.1
0.04
34
214
(3006504) Eosinophils/100 leukocytes in Blood
259
2276
1.24
1.86
8.1
5.4
%
2.9
2.8
0.04
246
2088
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
175
1.69
1.86
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
46
2.42
1.86
1.2
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
17
3.55
1.84
1.3
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
263
2318
1.24
1.83
7.8
5.4
%
58.1
56.8
0.97
249
2142
(3021960) Folate [Moles/volume] in Serum or Plasma
147
1212
1.28
1.82
1.5
1.5
nmol/l
22.8
22.4
0.09
125
1023
(1616796) Gas panel - Central venous blood
15
73
2.08
1.82
9.1
3.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
587
5732
1.91
1.81
29.0
16.9
e9/l
265.3
263.6
0.26
578
5579
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
35
2.59
1.80
1.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
23
3.07
1.80
1.3
2.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
587
5733
1.90
1.79
28.9
16.9
fl
91.5
91.0
2.04
581
5645
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
177
1.67
1.79
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
50
348
1.48
1.78
3.5
2.6
e9/l
4.4
4.1
0.49
32
270
(3035941) MCH [Entitic mass]
587
5734
1.89
1.78
28.8
16.8
pg
30.3
30.2
1.20
581
5646
(3026361) Erythrocytes [#/volume] in Blood
587
5734
1.89
1.78
29.0
16.9
e12/l
4.3
4.4
3.94
578
5565
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
249
2188
1.24
1.77
2.0
2.0
pmol/l
99.6
100.0
0.04
130
1028
(3010813) Leukocytes [#/volume] in Blood
587
5735
1.89
1.76
29.0
17.0
e9/l
6.7
6.6
1.10
578
5561
(3000963) Hemoglobin [Mass/volume] in Blood
587
5736
1.88
1.74
29.2
17.0
g/l
131.3
132.8
2.17
581
5649
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
163
1.69
1.74
2.4
4.5
%
1.7
1.5
0.61
27
157
(3025159) Blasts/100 leukocytes in Blood
50
350
1.47
1.73
4.3
4.0
%
0.0
1.6
0.54
17
57
(3045142) Bone marrow Pathology biopsy report
8
30
2.69
1.73
1.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
24
2.94
1.72
1.9
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
24
2.94
1.72
2.1
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
82
1.98
1.71
1.5
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
48
0.00
1.70
0.0
1.5
—
1.2
—
0
42
(3022096) Basophils/100 leukocytes in Blood
249
2200
1.22
1.66
8.3
5.5
%
0.7
0.7
0.85
235
2018
(3051611) Lipemic interference index of Serum or Plasma
11
49
2.27
1.64
2.6
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
515
4920
1.32
1.63
6.3
5.7
mmol/mol
39.5
39.5
0.01
477
4564
(3038026) Centromere Ab [Units/volume] in Serum
12
56
2.17
1.62
1.2
1.1
—
88.8
—
0
5
(40768446) Kidney Pathology biopsy report
5
14
3.59
1.62
1.4
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
274
1.49
1.56
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
352
3235
1.21
1.53
3.9
2.8
u/l
59.1
39.4
1.46
327
2998
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
464
1.37
1.51
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
235
1.52
1.50
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
101
1.81
1.50
2.7
1.9
g/l
125.6
131.5
0.38
11
72
(42870588) Differential panel, method unspecified - Blood
183
1583
1.22
1.47
8.4
5.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
423
1.38
1.47
4.1
3.1
ng/l
92.5
78.1
0.74
52
374
(3027273) Bicarbonate [Moles/volume] in Venous blood
31
204
1.55
1.46
3.5
2.6
mmol/l
24.7
25.6
1.09
31
197
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
40
2.27
1.40
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
46
2.19
1.40
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
92
740
1.29
1.39
2.1
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
147
1250
1.23
1.39
2.7
2.2
mg/l
3.7
2.9
2.38
125
1048
(1761868) Lipid panel - Serum or Plasma
160
1844
0.82
1.36
2.9
2.9
—
—
—
0
0
(3000492) Spirometry study
58
441
1.35
1.31
1.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
43
2.11
1.30
2.4
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
84
1.81
1.28
3.5
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
15
84
1.81
1.28
14.7
3.5
kpa
8.4
8.5
0.03
15
84
(3037756) Immunofixation for Serum or Plasma
15
84
1.81
1.28
1.3
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
15
84
1.81
1.28
14.7
3.5
kpa
5.2
5.1
0.05
15
84
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
55
2.02
1.28
2.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
264
2393
1.18
1.25
2.4
2.3
nmol/l
81.1
79.8
0.30
227
2125
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
453
1.34
1.25
3.3
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
36
2.24
1.24
2.5
2.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
63
1.92
1.23
4.1
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
78
1.81
1.22
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
125
1.62
1.19
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
26
2.32
1.19
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
38
2.12
1.18
1.1
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
50
2.02
1.17
5.5
2.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
72
1.82
1.16
1.5
1.6
%
60.6
59.4
—
8
45
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
524
5065
1.26
1.15
6.2
5.4
mu/l
2.0
2.1
0.21
485
4665
(3002179) Metamyelocytes/100 leukocytes in Blood
47
354
1.36
1.14
4.3
3.7
%
0.1
0.5
1.81
14
54
(4010399)
53
407
1.33
1.14
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
65
1.86
1.14
7.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
552
5372
1.33
1.13
5.5
5.0
mmol/l
2.8
2.8
0.81
504
4951
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
80
1.77
1.13
1.0
1.1
—
21.2
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
28
192
1.48
1.13
2.5
2.1
%
1.2
1.1
0.44
28
192
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
111
1.64
1.13
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
123
1050
1.22
1.12
1.8
1.3
g/l
2.1
2.3
0.41
68
609
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
26
176
1.50
1.12
1.4
1.2
u/ml
6.0
2.3
—
5
20
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
31
2.27
1.10
1.0
1.8
ug/l
4.5
11.3
—
7
23
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
21
2.39
1.09
1.6
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
186
1.47
1.08
4.8
8.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
289
1.37
1.06
1.5
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
48
369
1.33
1.04
3.4
3.0
pmol/l
4.5
4.5
0.02
41
316
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
677
1.24
1.03
4.2
2.6
e6/l
3.7
4.7
0.47
49
328
(3000330) Specific gravity of Urine by Test strip
18
274
0.65
1.03
3.9
3.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
26
180
1.46
1.02
1.4
1.3
u/ml
2.7
10.8
—
6
36
(3020630) Protein [Mass/volume] in Serum or Plasma
46
353
1.33
1.01
1.9
1.4
g/l
63.1
67.8
2.12
38
320
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
14
84
1.68
0.98
3.2
6.5
mmol/l
11.9
10.7
0.73
14
78
(3018572) Chloride [Moles/volume] in Blood
14
84
1.68
0.98
3.2
6.5
mmol/l
106.3
105.3
0.29
14
78
(3004119) Hemoglobin [Mass/volume] in Venous blood
35
259
1.37
0.97
3.3
2.5
g/l
121.1
127.7
1.11
35
249
(3001122) Ferritin [Mass/volume] in Serum or Plasma
257
2362
1.15
0.97
2.9
2.8
ug/l
116.8
82.8
1.76
234
2173
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
366
1.31
0.95
5.8
2.3
mmol/l
1.2
1.2
0.76
38
298
(3017704) Immunofixation for Urine
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
118
1.54
0.92
1.5
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
28
2.15
0.91
4.0
4.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
28
2.15
0.91
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
306
1.33
0.91
1.4
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
110
1.56
0.91
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
132
1495
0.85
0.90
1.7
1.6
mmol/l
1.5
1.4
0.76
107
1275
(1761482) Bacteria [#/volume] in Urine by Culture
7
127
0.55
0.89
1.9
4.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
228
0.65
0.87
1.3
1.8
mg/l
3.3
4.7
—
10
163
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(4211845)
6
31
1.94
0.84
4.0
4.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
121
1.50
0.83
5.2
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
146
1.45
0.83
1.2
1.4
ug/g
321.3
325.5
—
10
81
(40761536) Microorganisms panel - Urine sediment
50
401
1.27
0.83
4.3
3.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
46
1.75
0.82
3.7
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
32
1.88
0.82
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
130
1.48
0.81
5.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
81
688
1.20
0.80
3.9
4.6
%
33.1
33.7
0.17
52
447
(3048689) Calprotectin [Mass/mass] in Stool
81
688
1.20
0.80
2.1
2.1
ug/g
240.7
117.7
0.55
56
534
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
533
5201
1.21
0.79
5.4
4.6
mmol/l
5.9
5.9
1.06
493
4748
(3028300) Cannabinoids [Presence] in Urine
19
131
1.47
0.79
5.1
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
25
0.00
0.79
0.0
1.4
—
9.0
—
0
25
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
165
1.41
0.79
1.4
1.3
miu/ml
290.8
235.4
0.34
12
76
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
540
5278
1.22
0.77
5.0
4.5
mmol/l
4.8
4.9
1.44
498
4886
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
29
218
1.35
0.76
3.6
2.2
u/l
40.4
40.7
0.02
23
194
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
34
1.77
0.76
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
410
4265
0.88
0.76
20.8
13.5
%
13.8
13.6
2.66
400
4159
(3001019) Free T4 and TSH panel - Serum or Plasma
42
335
1.27
0.74
1.9
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
108
1.49
0.74
3.1
2.4
ug/min
32.9
46.7
—
7
67
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
25
2.01
0.73
4.6
2.6
u/ml
486.6
1199.5
—
5
25
(40767503) Oxygen content in Capillary blood by calculation
13
84
1.56
0.72
3.6
2.2
%
15.6
16.5
—
8
37
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
536
5242
1.20
0.72
4.8
4.5
mmol/l
1.5
1.6
1.82
488
4831
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
58
1.56
0.70
1.6
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
451
0.79
0.69
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
59
1.53
0.68
1.6
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
59
1.53
0.68
1.6
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
120
1071
1.15
0.67
1.3
1.3
u/ml
6.3
11.3
0.53
50
412
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
304
1.27
0.67
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
18
128
1.42
0.66
3.3
5.8
mmol/l
1.4
1.2
0.34
18
117
(3040151) Glucose [Moles/volume] in Capillary blood
7
44
1.60
0.65
1.4
1.8
mmol/l
6.3
7.1
—
7
34
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
138
1.39
0.63
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
120
1077
1.14
0.63
1.4
1.3
iu/ml
24.4
37.7
0.98
32
365
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
130
1.40
0.62
5.4
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
30
1.67
0.61
1.2
1.2
—
2.8
—
0
5
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
105
1.44
0.60
5.9
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
20
0.00
0.60
0.0
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
64
1.57
0.59
1.4
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
18
132
1.37
0.57
1.8
1.9
ug/l
148.2
169.1
0.19
18
118
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
36
1.67
0.57
1.0
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
36
1.67
0.57
2.7
2.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
212
1.29
0.56
4.7
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
37
1.63
0.55
1.7
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
215
0.74
0.53
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
66
1.52
0.53
1.5
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
63
1.43
0.52
3.7
1.7
%
62.7
60.1
—
9
63
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
203
0.73
0.52
1.3
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
83
1.45
0.52
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
83
1.45
0.52
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3013512) EKG study
157
1452
1.11
0.51
4.0
3.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
41
1.47
0.50
1.0
1.1
mg/l
20.4
25.0
—
6
33
(3003327) Ova and parasites identified in Stool by Light microscopy
13
178
0.72
0.49
1.7
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(4268621)
7
47
1.49
0.47
2.0
2.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(4062490)
7
48
1.46
0.47
2.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
123
1133
1.11
0.44
1.6
1.7
pmol/l
453.1
28480105.6
1.31
102
934
(3022621) pH of Urine by Test strip
43
369
1.18
0.43
3.5
3.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
131
1.31
0.42
5.7
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
140
1.29
0.42
2.2
1.3
—
—
—
0
0
(4027681)
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
79.0
—
0
6
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
456
1.15
0.41
1.2
1.2
iu/ml
94.1
145.4
0.86
22
191
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
442
0.85
0.40
1.7
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
25
205
1.23
0.40
1.4
1.8
—
9.5
—
0
5
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
101
0.69
0.40
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
87
793
1.11
0.38
1.6
1.3
titre
640.0
690.2
0.08
23
189
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
252
1.20
0.38
1.4
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
98
1.33
0.37
4.5
3.2
e9/l
3.4
4.3
1.69
13
98
(3020491) Glucose [Moles/volume] in Blood
5
37
1.35
0.37
1.8
1.4
mmol/l
6.0
7.1
—
5
22
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
108
1.30
0.35
2.6
3.7
mg/l
19.0
21.7
—
7
66
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
100
1.31
0.34
4.8
3.5
%
56.9
59.4
0.30
13
100
(40768797) Stomach Pathology biopsy report
85
783
1.10
0.32
1.1
1.2
—
—
—
0
0
(4024509)
7
53
1.32
0.31
1.6
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
75
1.34
0.30
5.2
5.3
umol/l
315.5
378.7
—
10
63
(3005570) Glucose [Moles/volume] in Urine
7
55
1.28
0.30
1.9
2.6
—
—
—
0
0
(4094501)
12
152
0.79
0.29
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
148
1.22
0.29
3.2
2.4
g/l
0.1
0.3
—
7
34
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
85
1.30
0.28
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
63
1.27
0.28
1.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
140
1.22
0.27
1.4
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
104
1.26
0.26
2.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
41
454
0.90
0.24
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
77
1.17
0.24
1.2
1.2
nmol/l
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
78
1.29
0.24
5.3
1.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
38
1.32
0.23
1.0
2.1
pg
30.2
32.6
—
5
38
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
153
1.18
0.22
1.9
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
46
421
1.10
0.21
1.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
44.4
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
5.4
—
0
10
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.1
—
109.3
—
0
10
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
1.5
—
0
12
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
89.0
—
0
12
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
3.2
—
6.1
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
45
413
1.10
0.20
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.1
—
85.5
—
0
6
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
394
1.10
0.20
2.3
3.0
ng/l
245.7
183.3
0.31
37
367
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
47
433
1.09
0.20
3.0
1.8
u/l
29.1
34.2
0.70
37
356
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
312
0.89
0.19
1.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
81
1.24
0.19
1.5
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
60
1.17
0.18
1.7
1.8
%
90.2
90.1
—
7
60
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
67
0.74
0.17
1.0
1.0
—
0.7
—
0
25
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
101
1.19
0.16
1.6
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
71
1.13
0.16
3.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
78
0.77
0.15
1.5
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
83
1.21
0.15
1.2
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
140
0.85
0.15
1.3
1.2
g/l
33.6
38.3
—
7
124
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
607
1.06
0.14
1.6
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
471
4667
1.04
0.14
16.2
12.6
%
38.9
39.2
0.30
298
3308
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
284
0.91
0.13
2.4
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
117
0.85
0.13
1.4
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
146
1423
1.03
0.11
3.9
3.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
86
1.17
0.11
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
125
1.12
0.10
1.4
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
12
135
0.89
0.10
1.3
1.2
mmol/l
3.6
3.8
0.63
12
123
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
213
1.08
0.09
1.5
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
6
55
1.09
0.09
1.2
1.0
—
2.7
—
0
16
(3014051) Protein [Presence] in Urine by Test strip
12
134
0.89
0.09
2.1
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
60
0.83
0.08
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
66
1.06
0.08
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
73
0.82
0.07
1.3
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
74
0.81
0.07
1.0
1.1
%
127.0
120.1
—
6
68
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
74
1.08
0.07
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
89
1.13
0.07
1.0
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
173
0.92
0.06
1.7
2.0
iu/l
2.1
5.7
—
6
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
327
3243
1.02
0.06
3.2
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1267
1.02
0.06
1.3
1.3
u/ml
0.8
1.9
1.77
27
334
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
922
1.02
0.05
3.5
3.8
ng/l
80.4
339.6
1.75
66
681
(3050129) First trimester maternal screen panel - Serum or Plasma
13
139
0.93
0.03
1.3
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
10
92
1.09
0.03
1.2
1.2
—
0.5
—
0
6
(1002224) Polysomnography panel
20
209
0.96
0.03
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
316
0.98
0.00
1.8
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
164
0.97
0.00
1.7
1.6
—
435.6
—
0
9
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
147
1.02
0.00
1.3
1.3
mg/l
434.0
468.5
0.20
15
135
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
102
0.98
0.00
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
108
1.02
0.00
1.9
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
118
1.02
0.00
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
148
1.01
0.00
2.4
1.3
g/l
1.2
0.3
—
9
135
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
168
1.01
0.00
1.5
1.3
g/l
7.2
10.3
—
9
146
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
168
1.01
0.00
2.1
1.3
g/l
3.1
3.0
—
8
135
(3005033) Fetal Nuchal fold Thickness US
10
99
1.01
0.00
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
119
1.01
0.00
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
119
1.01
0.00
1.2
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
179
1.01
0.00
2.0
1.3
g/l
7.5
7.6
—
8
137
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
179
1.01
0.00
2.0
1.3
g/l
3.8
3.7
—
8
132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
179
1.01
0.00
2.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4306422)
7
70
1.00
0.00
1.3
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
10.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
87
0.92
0.00
2.4
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
59
1.02
0.00
1.7
2.3
mmol/l
3.9
4.0
—
6
59
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
100
1.00
0.00
1.3
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
6.9
—
—
—
0
0
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.1
—
2.1
—
0
14
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
6.9
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
181.0
—
0
5
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
58
0.86
0.00
1.8
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
108.3
—
0
7
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.1
—
0.6
—
0
8
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
88
0.91
0.00
2.3
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
59
1.02
0.00
1.7
2.3
mmol/l
104.3
105.7
—
6
59
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
54
0.93
0.00
1.6
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
84
0.95
0.00
1.4
2.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_GENITAL_EXALLC – Carcinoma in situ of other and unspecified genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).